Agenda

Return

C.108

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	September 10, 2019

Contra

Costa

County

Subject:

Amendment #76-564-2 with Prometheus Laboratories, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 09/10/2019

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

ABSENT:

John Gioia, District I Supervisor

Contact:	Jaspreet Benepal, 925-370-5741
cc:	L Walker M Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: September 10, 2019
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County Contract Amendment Agreement #76-564-2 with Prometheus Laboratories, Inc., a corporation, effective May 15, 2019, to amend Contract #76-564-1, to modify the fee schedule to reduce rates and continue to provide outside laboratory testing services for Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, with no change in the original payment limit of $300,000, and no change in the original term of November 1, 2017 through October 31, 2020.

FISCAL IMPACT:

This Contract is funded 100% by Hospital Enterprise Fund I. (No rate increase)

BACKGROUND:

On April 10, 2018, the Board of Supervisors approved Contract #76-564-1 with Prometheus Laboratories, Inc., to provide outside laboratory testing services including testing for patients diagnosed with Hepatitis C, to reduce the number of liver biopsies performed at CCRMC and Contra Costa Health Centers, for the period from November 1, 2017 through October 31, 2020.

Approval of Amendment Agreement #76-564-2 will allow Contractor to provide outside laboratory testing services at a reduced rate through October 31, 2020.

CONSEQUENCE OF NEGATIVE ACTION:

If this amendment is not approved, patients requiring outside testing services for liver abnormalities will not have access to Contractor’s services at a lower rate.